Figure 1.
Response status (CR or R for phase 2 and at least R for the extension phase), rescue treatments, exposure to eltrombopag, and discontinuation or death during phase 2 and extension phase for all 18 patients.
Response status (CR or R for phase 2 and at least R for the extension phase), rescue treatments, exposure to eltrombopag, and discontinuation or death during phase 2 and extension phase for all 18 patients.